Jci_page_head_homepage_01 Jci_page_head_homepage_02
Rakesh Verma, Iulia Kovari, Abdul Soofi, Deepak Nihalani, Kevin Patrie, Lawrence B. Holzman
Published in Volume 116, Issue 5
J Clin Invest. 2006; 116(5):1346–1359 doi:10.1172/JCI27414
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
Characterization of a P-nephrin polyclonal antibody.

(A) Cell lysate — obtained from COS7 cells transfected as labeled with plasmid encoding mouse nephrin and treated with or without pervanadate — was analyzed as indicated by immunoblotting with affinity-purified rabbit polyclonal anti–P-nephrin. (B) Mouse kidney was perfused with pervanadate or PBS; subsequent to glomerular isolation and extraction, glomerular lysate was resolved by SDS-PAGE and immunoblotted for P-nephrin. (C) SYF mouse embryonic fibroblasts were transiently transfected with plasmid encoding nephrin or the indicated nephrin mutants and treated or not treated with pervanadate prior to cell lysis. Cell lysates were resolved by SDS-PAGE and immunoblotted with indicated antibodies. (D) COS7 cells were transiently transfected with plasmids encoding nephrin or the indicated nephrin mutants and with Fyn or a control plasmid. Obtained cell lysates were resolved by SDS-PAGE and immunoblotted with indicated antibodies. (E) Top panels: Adult mouse kidneys were perfused with PBS or pervanadate and were subsequently examined by indirect immunofluorescence (IF) using the indicated primary antibodies. Bottom panels: Indirect immunofluorescence microscopy and phase-contrast microscopy of identical fields was used to confirm absence of P-nephrin staining in glomeruli (see Figure 4). Magnification, ×40 (top 4 panels); ×20 (bottom 2 panels).